These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3790224)

  • 1. [Seroconversion with measles vaccine in children 8-18 months old].
    Díaz-Ortega JL; Zárate-Aquino ML; Valdespino-Gómez JL; Cardenas-Ayala VM; Ruíz-Matus C
    Bol Med Hosp Infant Mex; 1986 Sep; 43(9):526-31. PubMed ID: 3790224
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response to measles immunization in India.
    Job JS; John TJ; Joseph A
    Bull World Health Organ; 1984; 62(5):737-41. PubMed ID: 6334571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion rates and measles antibody titers induced by measles vaccine in Latin American children 6-12 months of age. Collaborative Study by the Ministries of Health of Brazil, Chile, Costa Rica, Ecuador, and the Pan American Health Organization.
    Bull Pan Am Health Organ; 1982; 16(3):272-85. PubMed ID: 7171892
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to measles immunization and the impacts on HIV-infected children.
    Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 10. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
    al-Attar I; Reisman J; Muehlmann M; McIntosh K
    Pediatr Infect Dis J; 1995 Feb; 14(2):149-51. PubMed ID: 7746699
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to measles vaccine in 6 month old infants in Papua New Guinea.
    Kurubi J; Vince J; Ripa P; Tefuarani N; Riddell M; Duke T
    Trop Med Int Health; 2009 Feb; 14(2):167-73. PubMed ID: 19171008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.